What is the average price target for AMDOCS LTD (DOX) stock?
12 analysts have analysed DOX and the average price target is 93.02 USD. This implies a price increase of 40.85% is expected in the next year compared to the current price of 66.04.
NASDAQ:DOX • GB0022569080
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for AMDOCS LTD (DOX).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-02-05 | Barclays | Maintains | Overweight -> Overweight |
| 2026-02-04 | Stifel | Maintains | Buy -> Buy |
| 2025-11-13 | Wolfe Research | Downgrade | Outperform -> Peer Perform |
| 2025-11-12 | Stifel | Maintains | Buy -> Buy |
| 2025-11-12 | B of A Securities | Maintains | Buy -> Buy |
| 2025-07-08 | Wolfe Research | Initiate | Outperform |
| 2024-11-14 | Barclays | Maintains | Overweight -> Overweight |
| 2024-11-13 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-10-02 | Stifel | Initiate | Buy |
| 2024-05-09 | Baird | Maintains | Neutral -> Neutral |
| 2024-05-09 | Citigroup | Maintains | Buy -> Buy |
| 2024-02-08 | Barclays | Maintains | Overweight -> Overweight |
| 2024-01-17 | Citigroup | Maintains | Buy -> Buy |
| 2023-12-01 | Jefferies | Initiate | Buy |
| 2023-08-03 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2023-05-16 | Barclays | Upgrade | Equal-Weight -> Overweight |
| 2023-05-11 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2023-02-02 | Baird | Maintains | Neutral |
| 2023-02-01 | Oppenheimer | Maintains | Outperform |
| 2022-11-09 | Citigroup | Maintains | Buy |
| 2022-08-04 | Barclays | Maintains | Equal-Weight |
| 2022-08-04 | Citigroup | Maintains | Buy |
| 2022-05-12 | Citigroup | Maintains | Buy |
| 2021-12-14 | JP Morgan | Downgrade | Overweight -> Neutral |
| 2021-08-05 | Oppenheimer | Maintains | Outperform |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 4.888B 6.79% | 5.005B 2.40% | 4.533B -9.43% | 4.736B 4.48% | 4.914B 3.76% | 5.186B 5.54% | 5.335B 2.87% | 5.547B 3.97% | 5.776B 4.13% | 6.007B 4.00% | |
| EBITDA YoY % growth | 920.592M 3.51% | 952.762M 3.49% | 1.008B 5.76% | 1.235B 22.56% | 1.272B 3.00% | 1.366B 7.39% | 1.42B 3.95% | 1.482B 4.37% | 1.531B 3.31% | 1.592B 3.98% | |
| EBIT YoY % growth | 724.891M 9.04% | 759.696M 4.80% | 812.203M 6.91% | 1.026B 26.32% | 1.082B 5.46% | 1.154B 6.65% | N/A | N/A | N/A | N/A | |
| Operating Margin | 14.83% | 15.18% | 17.92% | 21.66% | 22.02% | 22.25% | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | 5.91 11.51% | 6.44 8.97% | 6.99 8.54% | 7.52 7.61% | 8.18 8.79% | 8.88 8.55% | 9.89 11.31% | 10.73 8.48% | N/A | N/A |
All data in USD
| Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 1.78 0.05% | 1.90 10.64% | 2.01 10.04% | 1.98 9.31% | 1.95 9.43% | 2.05 7.71% | 2.16 7.13% |
| Revenue Q2Q % growth | 1.179B 4.50% | 1.188B 3.81% | 1.201B 4.41% | 1.206B 4.33% | 1.209B 2.54% | 1.221B 2.78% | 1.227B 2.16% |
| EBITDA Q2Q % growth | 295.03M 1.54% | 303.41M -12.04% | 315.65M -21.44% | 308.77M 14.90% | 299.29M 1.44% | 306.8M 1.12% | 310.52M -1.63% |
| EBIT Q2Q % growth | 249.19M 26.02% | 256.61M 26.74% | 268.17M 29.94% | 264.91M 21.53% | 262.73M 5.43% | 270.23M 5.31% | 273.95M 2.16% |
All data in USD
12 analysts have analysed DOX and the average price target is 93.02 USD. This implies a price increase of 40.85% is expected in the next year compared to the current price of 66.04.
AMDOCS LTD (DOX) will report earnings on 2026-05-05.
The consensus EPS estimate for the next earnings of AMDOCS LTD (DOX) is 1.78 USD and the consensus revenue estimate is 1.18B USD.
The consensus rating for AMDOCS LTD (DOX) is 81.6667 / 100 . This indicates that analysts generally have a positive outlook on the stock.